© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
The Board is accountable to Shareholders for the overall direction, management and corporate governance of Osprey Medical. It has adopted practices and procedures for the corporate governance of Osprey Medical, which establish the framework of how the Directors carry out their duties and obligations on behalf of shareholders.
The Board’s responsibilities include:
- Monitoring and ensuring compliance with best practice corporate governance requirements
- Promotion of high standards of corporate governance
Key documents and policies, which form part of our corporate governance framework and highlight our significant commitment to corporate governance, are set out below:
Board and Committee
|Anti-Bribery and Corruption Policy||148 KB||Download|
|Whistleblower Policy||77 KB||Download|
|Shareholder Communications Policy||126 KB||Download|
|Code of Conduct||107 KB||Download|
|Continuous Disclosure Policy||135 KB||Download|
|Securities Trading Policy||164 KB||Download|
|Diversity Policy||97 KB||Download|
|Risk Management Policy||95 KB||Download|